Greenwich LifeSciences (GLSI) Proxy filing summary

Executive summary

• Annual Meeting scheduled for December 19, 2024, at 9:00 a.m. in New York, NY.

• Proxy materials and 2023 Annual Report are available online, with options for paper or email copies upon request.

• Voting can be conducted online, by mail, or in person, with specific instructions provided for each method.

Voting matters and shareholder proposals

• Election of five directors: David B. McWilliams, Snehal S. Patel, Eric Rothe, F. Joseph Daugherty, MD, and Kenneth Hallock.

• Ratification of RBSM LLP as independent registered public accountants for fiscal year ending December 31, 2024.

• Approval of amendment to the 2019 Equity Incentive Plan, increasing reserved shares from 1,500,000 to 4,000,000.

• Board recommends voting "FOR" all nominees and proposals.

Board of directors and corporate governance

• Five director nominees are presented for election at the annual meeting.

• Board leadership includes David B. McWilliams as Chairman.